AHA Comments to FDA Re: Blood Glucose Monitoring Test Systems

AHA's comment on the Food and Drug Administration’s draft guidance on blood glucose monitoring test systems for prescription point-of-care use.

View the following letter for details. 

Related Resources

AHA Center for Health Innovation Market Scan
Keep an Eye on Clinical Validation Gaps in AI-Enabled Medical Devices
Public
AHA Center for Health Innovation Market Scan
How Do Health Executives View AI? 3 Takeaways from New Survey
Public
AHA Center for Health Innovation Market Scan
Endeavor Health, Northwestern Develop AI Program to Detect Lung Disorder
Public
Advancing Health Podcast
HCA’s AI-Driven Patient Safety Evolution, Part 1
AHA Center for Health Innovation Market Scan
Improving Survival Rates for Surgical Patients: 3 Takeaways
Public
Guides/Reports
New Analysis Connects Better Outcomes for Hospitalized Surgical Patients to Improvements in Key Patient Safety Indicators
Public